This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.

Top Stories

 

  •  

    Media Invite: ESMO 2014

  •  

    The Power of 140 Characters: When Social Media met the ESC Congress 2014

    Events and Initiatives

    ESMO 2014 Congress

    26th - 30th September
    Find out the latest news about Boehringer Ingelheim's treatments in oncology.

    Education Hub

     

     

    INFOGRAPHIC

    Nintedanib* Lume-Lung
    1 Clinical Trial

    INFOGRAPHIC

    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer